Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach-Reference-Cited by-同舟云学术

Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach

Published:2008-05-13 Issue:1 Volume:65 Page:307-315
ISSN:0006-341X
Container-title:Biometrics
language:en
Short-container-title:

Author:

Ivanova Anastasia,Kim Se Hee

Publisher

Wiley

Subject

Applied Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,Statistics and Probability

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1541-0420.2008.01045.x/fullpdf

Reference25 articles.

1. Cancer phase I clinical trials: Efficient dose escalation with overdose control;Babb;Statistics in Medicine,1998

2. A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial;Bekele;Biometrics,2005

3. Dose-finding based on multiple toxicities in a soft tissue sarcoma trial;Bekele;Journal of the American Statistical Association,2004

4. Coherence principles in dose finding studies;Cheung;Biometrika,2005

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design;Statistics in Medicine;2024-07-29

2. CRM and partial order CRM with adaptive rescaling for dose‐finding in immunotherapy trials with a continuous outcome;Statistics in Medicine;2023-04-03

3. Evaluation of phase I clinical trial designs for combinational agents along with guidance based on simulation studies;Journal of Applied Statistics;2022-08-03

4. An R package UnifiedDoseFinding for continuous and ordinal outcomes in Phase I dose-finding trials;Communications for Statistical Applications and Methods;2022-07-31

5. An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials;BMC Medical Research Methodology;2021-12